TFF Pharmaceuticals, Inc. is an early-stage biopharmaceutical company focused on the development and commercialization of new inhalation products for the treatment of chronic respiratory diseases and lung conditions.
In early testing the Thin Film Freezing (TFF) proprietary platform significantly improved the solubility of drugs that have poor water solubility.
TFF Pharmaceuticals Corporate Overview – March 2020
TFF Pharmaceuticals Reports Fourth Quarter Results and Full Year 2019 Financial and Business Results
March 26, 2020
TFF Pharmaceuticals Reschedules Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call for March 26, 2020 to 4:30 PM (EDT)
March 23, 2020
TFF Pharmaceuticals to Hold Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call on March 26, 2020
March 19, 2020